Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date

Alberto Gajofatto Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy Abstract: Siponimod (BAF312) is a synthetic molecule belonging to the sphingosine-1-phosphate (S1P) modulator family, which has putative neuroprotective properties and well-characteri...

Full description

Saved in:
Bibliographic Details
Main Author: Gajofatto A (Author)
Format: Book
Published: Dove Medical Press, 2017-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available